The latest closing stock price for Cullinan Therapeutics as of November 20, 2024 is 12.58.
An investor who bought $1,000 worth of Cullinan Therapeutics stock at the IPO in 2021 would have $-579 today, roughly -1 times their original investment - a -19.47% compound annual growth rate over 4 years.
The all-time high Cullinan Therapeutics stock closing price was 53.42 on March 10, 2021.
The Cullinan Therapeutics 52-week high stock price is 30.19, which is 140% above the current share price.
The Cullinan Therapeutics 52-week low stock price is 7.64, which is 39.3% below the current share price.
The average Cullinan Therapeutics stock price for the last 52 weeks is 16.90.
An investor who bought $1,000 worth of Cullinan Therapeutics stock at the IPO in 2021 would have $-579 today, roughly -1 times their original investment - a -19.47% compound annual growth rate over 4 years.
The all-time high Cullinan Therapeutics stock closing price was 53.42 on March 10, 2021.
The Cullinan Therapeutics 52-week high stock price is 30.19, which is 140% above the current share price.
The Cullinan Therapeutics 52-week low stock price is 7.64, which is 39.3% below the current share price.
The average Cullinan Therapeutics stock price for the last 52 weeks is 16.90.